|
Report ID
|
212848 |
|
Drug Identification Number
|
02487721 |
|
Brand name
|
ACH-APIXABAN |
|
Common or Proper name
|
APIXABAN |
|
Company Name
|
ACCORD HEALTHCARE INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
APIXABAN |
|
Strength(s)
|
5MG |
|
Dosage form(s)
|
TABLET |
|
Route of administration
|
ORAL |
|
Packaging size
|
60 180 |
|
Anatomical Therapeutical Chemical (ATC) code
|
B01AF |
|
Anatomical Therapeutical Chemical (ATC) description
|
ANTITHROMBOTIC AGENTS |
|
Reason for shortage
|
Disruption of the manufacture of the drug. |
|
Anticipated start date
|
|
|
Actual start date
|
2023-12-08 |
|
Estimated end date
|
2024-03-14 |
|
Actual end date
|
2024-03-15 |
|
Shortage status
|
Resolved |
|
Updated date
|
2024-03-16 |
|
Company comments
|
|
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
